Singapore - English - HSA (Health Sciences Authority)

viatris private limited - atorvastatin calcium43.40mg eqv atorvastatin - tablet, film coated - 40mg - atorvastatin calcium43.40mg eqv atorvastatin 40mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - amlodipine besylate eqv amlodipine (extra-granular ingredients); atorvastatin calcium eqv atorvastatin (atorvastatin granulation) - tablet, film coated - 10 mg - amlodipine besylate eqv amlodipine (extra-granular ingredients) 10 mg; atorvastatin calcium eqv atorvastatin (atorvastatin granulation) 10 mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - amlodipine besylate eqv amlodipine (extra-granular ingredients); atorvastatin calcium eqv atorvastatin (atorvastatin granulation) - tablet, film coated - 10 mg - amlodipine besylate eqv amlodipine (extra-granular ingredients) 10 mg; atorvastatin calcium eqv atorvastatin (atorvastatin granulation) 20 mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - amlodipine besylate eqv amlodipine (extra-granular ingredients); atorvastatin calcium eqv atorvastatin (atorvastatin granulation) - tablet, film coated - 5 mg - amlodipine besylate eqv amlodipine (extra-granular ingredients) 5 mg; atorvastatin calcium eqv atorvastatin (atorvastatin granulation) 10 mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - amlodipine besylate eqv amlodipine (extra-granular ingredients); atorvastatin calcium eqv atorvastatin (atorvastatin granulation) - tablet, film coated - 5 mg - amlodipine besylate eqv amlodipine (extra-granular ingredients) 5 mg; atorvastatin calcium eqv atorvastatin (atorvastatin granulation) 20 mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - amlodipine besylate eqv amlodipine (extra-granular ingredients); atorvastatin calcium eqv atorvastatin (atorvastatin granulation) - tablet, film coated - 5 mg - amlodipine besylate eqv amlodipine (extra-granular ingredients) 5 mg; atorvastatin calcium eqv atorvastatin (atorvastatin granulation) 40 mg

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - tablets - atorvastatin as calcium 10 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are prese

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - tablets - atorvastatin as calcium 20 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are prese

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - tablets - atorvastatin as calcium 40 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are prese

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - tablets - atorvastatin as calcium 80 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are prese